Condition
Chronic Eczema
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Early P 1 (1)
P 4 (2)
Trial Status
Unknown2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04016025Phase 4Completed
A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers
NCT03485560Early Phase 1UnknownPrimary
Revitalization of Damaged Skin Due to Chronic Skin Diseases
NCT02601222Phase 4UnknownPrimary
Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema
Showing all 3 trials